Table 1 of
Chaturvedi, Mol Vis 2025; 31:10-21. Table 1 of
Chaturvedi, Mol Vis 2025; 31:10-21.
Table 1. Association of the age, hemoglobin, plasma glucose and brain natriuretic peptide levels with stages of diabetic retinopathy.
| Study variables | Mean ± SD | Range | P value | |
|---|---|---|---|---|
| Age* | Control | 54.5±6.1 | 46–67 | 0.051 |
| (years) | No DR | 55.0±5.4 | 45–63 | |
| NPDR | 53.8±6.6 | 44–68 | ||
| PDR | 55.1±5.4 | 45–63 | ||
| HbA1c* (%) | Control | 4.8±0.5 | 4.0–5.9 | <0.001 |
| No DR | 7. 8±0.4 | 7.0–8.4 | ||
| NPDR | 8.5±1.5 | 5.6–11.0 | ||
| PDR | 9.1±1.1 | 7.2–11.0 | ||
| Fasting plasma glucose* (mg/dl) | Control | 91.2±21.0 | 66–133 | <0.001 |
| No DR | 112.8±14.8 | 91–140 | ||
| NPDR | 126.9±37.8 | 68–200 | ||
| PDR | 148.8±43.8 | 81–248 | ||
| 2-h plasma glucose* (mg/dl; PPBS) | Control | 124.9±19.5 | 99–167 | <0.001 |
| No DR | 166.8±20.4 | 141–208 | ||
| NPDR | 203.1±52.5 | 112–293 | ||
| PDR | 211.8±63.9 | 143–362 | ||
| Serum Pro BNP* (pg/ml) | Control | 14.1±11.5 | 2.6–53.30 | <0.001 |
| No DR | 27.4±11.8 | 13–56.68 | ||
| NPDR | 280.4±106.1 | 125–450.80 | ||
| PDR | 122.3±43.6 | 69.31–197.95 |